Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Baseline bloodwork CBC, CRP, ferritin, IL-6, cortisol AM, metabolic panel, thyroid function Cardiovascular assessment heart rate variability, orthostatic vitals if POTS is suspected Gut health markers stool testing, zonulin, calprotectin if GI symptoms are prominent Mitochondrial function proxies lactate, organic acids panel if PEM is a primary complaint From there, a typical protocol might be structured as: Phase 1 (Weeks 16): Immune and gut foundation Thymosin Alpha-1: 1.6 mg subcutaneous, twice weekly BPC-157: 250500 mcg daily, route determined by predominant symptom (oral for gut, injectable for systemic) Phase 2 (Weeks 412): Tissue repair and cardiovascular recovery TB-500: 2.02.5 mg subcutaneous, twice weekly Continue BPC-157 as indicated Phase 3 (Weeks 816): Maintenance and metabolic support Taper or pulse doses based on clinical response Add mitochondrial support if fatigue persists (see: Mitochondrial Peptides and Insulin Resistance) These are illustrative dosing ranges based on clinical research and published protocols
No, BPC 157 is not an antibiotic
Concentration accuracy is harder than it looks The 0.9% benzyl alcohol target is a narrow window with consequences on both sides: Too little benzyl alcohol (below ~0.5%) and the bacteriostatic effect weakens significantly, allowing bacterial growth in the multi-dose vial during the 28-day use window Too much benzyl alcohol (above ~2%) and tissue toxicity becomes a concern published research has documented injection site irritation, tissue damage, and in extreme concentrations, systemic toxicity from benzyl alcohol exposure For a 30 mL batch, the target benzyl alcohol volume is 0.27 mL roughly five drops from a standard dropper
BPC-157 dominates clinic menus and podcast conversations, yet it rests on only three small human studies
Peptide therapy tends to do its best work as part of a longer-term wellness plan rather than a single visit
Why KLOW Is Studied as a Multi-Pathway Blend The logic behind KLOW is overlap
US$ 21.89
US$ 26.58
US$ 29.58
US$ 20.87
US$ 22.89
US$ 23.74
US$ 27.74
US$ 25.95
US$ 26.23